II
BLCM

Inspire Investing’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Inspire Investing’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-29
Closed – – 757
2020
Q1 		$0 Buy
+29
New +$311 ﹤0.01% 814
2018
Q1 		– Sell
-11
Closed -$1K – 768
2017
Q4 		$1K Buy
+11
New +$1.08K ﹤0.01% 902

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Inspire Investing's BLCM Position: Q2 2020 in Review

Inspire Investing sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2020, closing a stake of 29 shares.

Inspire Investing first reported a position in BLCM in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 27 funds tracked by Wall St. Rank hold BLCM as of Q2 2020.

  • Inspire Investing reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Inspire Investing sold 29 Bellicum Pharmaceuticals, Inc. shares in Q2 2020.
  • Inspire Investing first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
  • Inspire Investing's Bellicum Pharmaceuticals, Inc. position peaked at $1K in Q4 2017.
  • 27 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2020.

Based on Inspire Investing's 13F filing for Q2 2020, filed 12 Aug 2020.